I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 14 studies | 26% ± 8% | |
| epithelial cell | 9 studies | 36% ± 14% | |
| basal cell | 8 studies | 26% ± 10% | |
| abnormal cell | 7 studies | 24% ± 6% | |
| B cell | 6 studies | 33% ± 8% | |
| plasmablast | 6 studies | 32% ± 17% | |
| connective tissue cell | 6 studies | 30% ± 7% | |
| CD8-positive, alpha-beta T cell | 6 studies | 38% ± 14% | |
| ciliated cell | 6 studies | 27% ± 10% | |
| erythrocyte | 6 studies | 29% ± 16% | |
| non-classical monocyte | 5 studies | 29% ± 10% | |
| conventional dendritic cell | 5 studies | 28% ± 7% | |
| progenitor cell | 5 studies | 23% ± 5% | |
| T cell | 5 studies | 37% ± 6% | |
| natural killer cell | 5 studies | 27% ± 10% | |
| pericyte | 5 studies | 24% ± 7% | |
| smooth muscle cell | 5 studies | 24% ± 8% | |
| transit amplifying cell | 5 studies | 33% ± 11% | |
| CD4-positive, alpha-beta T cell | 5 studies | 43% ± 16% | |
| hematopoietic precursor cell | 4 studies | 37% ± 14% | |
| endothelial cell | 4 studies | 29% ± 9% | |
| myofibroblast cell | 4 studies | 25% ± 5% | |
| macrophage | 4 studies | 28% ± 1% | |
| erythroblast | 4 studies | 49% ± 25% | |
| plasma cell | 4 studies | 32% ± 3% | |
| pro-B cell | 4 studies | 31% ± 8% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 7% | |
| plasmacytoid dendritic cell | 4 studies | 25% ± 5% | |
| deuterosomal cell | 3 studies | 22% ± 4% | |
| goblet cell | 3 studies | 23% ± 7% | |
| mesothelial cell | 3 studies | 31% ± 11% | |
| neural crest cell | 3 studies | 49% ± 19% | |
| extravillous trophoblast | 3 studies | 56% ± 20% | |
| lymphocyte | 3 studies | 23% ± 9% | |
| dendritic cell | 3 studies | 32% ± 10% | |
| granulocyte monocyte progenitor cell | 3 studies | 41% ± 30% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 39% ± 14% | |
| precursor B cell | 3 studies | 50% ± 21% |
